drugset

drugset / Trial / NCT00398125

Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

NCT00398125 ↗

Phase 2 Completed 30 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate safety, tolerability and anti-viral activity in Integrase-Naïve HIV-1 infected adults

Timeline

Start: 2006-11
Primary completion: —
Completion: 2007-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GSK364735	Small molecule	—	—

Indications